Prostate stem cell antigen - novel biomarker and therapeutic target?

Detalhes bibliográficos
Autor(a) principal: Santos, PB
Data de Publicação: 2014
Outros Autores: Patel, HR
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.10/2271
Resumo: Prostate stem cell antigen gene was originally identified through an analysis of genes upregulated in the human prostate cancer LAPC-4 xenograft model. PSCA was named inaccurately since it is not a marker for a stem cell population nor is it exclusively expressed in the prostate. The function of PSCA in normal cellular processes or carcinogenesis is currently unknown.
id RCAP_1c95110b3839b782fc9dd1e656b27860
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/2271
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Prostate stem cell antigen - novel biomarker and therapeutic target?Tumor biomarkersProstatic neoplasmsProstate stem cell antigen gene was originally identified through an analysis of genes upregulated in the human prostate cancer LAPC-4 xenograft model. PSCA was named inaccurately since it is not a marker for a stem cell population nor is it exclusively expressed in the prostate. The function of PSCA in normal cellular processes or carcinogenesis is currently unknown.Taylor & FrancisRepositório do Hospital Prof. Doutor Fernando FonsecaSantos, PBPatel, HR2019-05-23T14:48:20Z2014-01-01T00:00:00Z2014-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/2271engExpert Rev Anticancer Ther. 2014 Jan;14(1):5-71744-832810.1586/14737140.2014.870481metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:52:58Zoai:repositorio.hff.min-saude.pt:10400.10/2271Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:53:13.889480Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Prostate stem cell antigen - novel biomarker and therapeutic target?
title Prostate stem cell antigen - novel biomarker and therapeutic target?
spellingShingle Prostate stem cell antigen - novel biomarker and therapeutic target?
Santos, PB
Tumor biomarkers
Prostatic neoplasms
title_short Prostate stem cell antigen - novel biomarker and therapeutic target?
title_full Prostate stem cell antigen - novel biomarker and therapeutic target?
title_fullStr Prostate stem cell antigen - novel biomarker and therapeutic target?
title_full_unstemmed Prostate stem cell antigen - novel biomarker and therapeutic target?
title_sort Prostate stem cell antigen - novel biomarker and therapeutic target?
author Santos, PB
author_facet Santos, PB
Patel, HR
author_role author
author2 Patel, HR
author2_role author
dc.contributor.none.fl_str_mv Repositório do Hospital Prof. Doutor Fernando Fonseca
dc.contributor.author.fl_str_mv Santos, PB
Patel, HR
dc.subject.por.fl_str_mv Tumor biomarkers
Prostatic neoplasms
topic Tumor biomarkers
Prostatic neoplasms
description Prostate stem cell antigen gene was originally identified through an analysis of genes upregulated in the human prostate cancer LAPC-4 xenograft model. PSCA was named inaccurately since it is not a marker for a stem cell population nor is it exclusively expressed in the prostate. The function of PSCA in normal cellular processes or carcinogenesis is currently unknown.
publishDate 2014
dc.date.none.fl_str_mv 2014-01-01T00:00:00Z
2014-01-01T00:00:00Z
2019-05-23T14:48:20Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/2271
url http://hdl.handle.net/10400.10/2271
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Expert Rev Anticancer Ther. 2014 Jan;14(1):5-7
1744-8328
10.1586/14737140.2014.870481
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Taylor & Francis
publisher.none.fl_str_mv Taylor & Francis
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130399633309696

Registros relacionados